Testing effectiveness (Phase 2)Study completedNCT00054132
What this trial is testing
Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer
Who this might be right for
Recurrent Breast CarcinomaStage IV Breast Cancer
National Cancer Institute (NCI) 38